This is not a library sponsored event.
Description of Event
Caregiver's Forum on Epilepsy and Autism: Panel Discussion & Guest Speakers
The moderated panel discussion will highlight useful information for caregivers and families affected by epilepsy and/or autism.
Bleuberi, a new Mobile Health Technology platform is conducting Panel Discussion with the non profit organization Whole Plant Access for Autism, to educate families on ways to best manage, find solutions and treatments for and take control of the many health issues related to epilepsy and autism. The discussion is an opportunity to learn about the ways innovative mobile health technologies easily helps keep track of seizures, daily health factors, routines, medications, vitals, and more. This includes key information from the panel guests about the use of medical cannabis in pediatric patients and the importance of tracking cannabis treatment.
Epilepsy: Epilepsy affects the lives of 3.4 million people in the United States according to the U.S. Center for Disease Control & Prevention (CDC.) Approximately 1 in 10 people will have at least one seizure in their lifetime, 1 in 26 will be diagnosed with epilepsy. Epilepsy kills more than 50,000 people annually in the United States. Bleuberi, knows that innovative technology like ours will lead to new insights for our individual users and in research.
Autism: In 2018 the CDC determined that approximately 1 in 59 children is diagnosed with an autism spectrum disorder (ASD). Boys are four times more likely to be diagnosed with autism than girls. Most children were still being diagnosed after age 4, though autism can be reliably diagnosed as early as age 2. A diagnosis of ASD now includes several conditions that used to be diagnosed separately: autistic disorder, pervasive developmental disorder not otherwise specified (PDD-NOS), and Asperger syndrome. These conditions are now all called autism spectrum disorder. More than 30% of those with autism also develop epilepsy.